160 related articles for article (PubMed ID: 31069134)
1. T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapy.
Brentville VA; Symonds P; Cook KW; Daniels I; Pitt T; Gijon M; Vaghela P; Xue W; Shah S; Metheringham RL; Durrant LG
Oncoimmunology; 2019; 8(5):e1576490. PubMed ID: 31069134
[TBL] [Abstract][Full Text] [Related]
2. Citrullinated Epitopes Identified on Tumour MHC Class II by Peptide Elution Stimulate Both Regulatory and Th1 Responses and Require Careful Selection for Optimal Anti-Tumour Responses.
Symonds P; Marcu A; Cook KW; Metheringham RL; Durrant LG; Brentville VA
Front Immunol; 2021; 12():764462. PubMed ID: 34858415
[TBL] [Abstract][Full Text] [Related]
3. Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy.
Brentville VA; Symonds P; Chua J; Skinner A; Daniels I; Cook KW; Koncarevic S; Martinez-Pinna R; Shah S; Choudhury RH; Vaghela P; Weston D; Al-Omari A; Davis J; Durrant LG
Front Immunol; 2022; 13():1066185. PubMed ID: 36544781
[TBL] [Abstract][Full Text] [Related]
4. Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses.
Brentville VA; Metheringham RL; Daniels I; Atabani S; Symonds P; Cook KW; Vankemmelbeke M; Choudhury R; Vaghela P; Gijon M; Meiners G; Krebber WJ; Melief CJM; Durrant LG
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32561639
[TBL] [Abstract][Full Text] [Related]
5. Citrullinated α-enolase is an effective target for anti-cancer immunity.
Cook K; Daniels I; Symonds P; Pitt T; Gijon M; Xue W; Metheringham R; Durrant L; Brentville V
Oncoimmunology; 2018; 7(2):e1390642. PubMed ID: 29308319
[TBL] [Abstract][Full Text] [Related]
6. Post-translational modifications such as citrullination are excellent targets for cancer therapy.
Brentville VA; Vankemmelbeke M; Metheringham RL; Durrant LG
Semin Immunol; 2020 Feb; 47():101393. PubMed ID: 31932199
[TBL] [Abstract][Full Text] [Related]
7. The role of posttranslational modifications in generating neo-epitopes that bind to rheumatoid arthritis-associated HLA-DR alleles and promote autoimmune T cell responses.
Becart S; Whittington KB; Prislovsky A; Rao NL; Rosloniec EF
PLoS One; 2021; 16(1):e0245541. PubMed ID: 33465118
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool.
Choudhury RH; Daniels I; Vaghela P; Atabani S; Kirk T; Symonds P; Cook KW; Al-Omari A; Weston D; Shah S; Hutchinson D; Paston SJ; Metheringham RL; Brentville VA; Durrant LG
Immunology; 2023 Aug; 169(4):467-486. PubMed ID: 37055914
[TBL] [Abstract][Full Text] [Related]
9. The increased ability to present citrullinated peptides is not unique to HLA-SE molecules: arginine-to-citrulline conversion also enhances peptide affinity for HLA-DQ molecules.
Kampstra AS; van Heemst J; Moustakas AK; Papadopoulos GK; Huizinga TW; Toes RE
Arthritis Res Ther; 2016 Nov; 18(1):254. PubMed ID: 27809896
[TBL] [Abstract][Full Text] [Related]
10. PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy.
Choudhury RH; Symonds P; Paston SJ; Daniels I; Cook KW; Gijon M; Metheringham RL; Brentville VA; Durrant LG
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35140112
[TBL] [Abstract][Full Text] [Related]
11. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.
Feitsma AL; van der Voort EI; Franken KL; el Bannoudi H; Elferink BG; Drijfhout JW; Huizinga TW; de Vries RR; Toes RE; Ioan-Facsinay A
Arthritis Rheum; 2010 Jan; 62(1):117-25. PubMed ID: 20039411
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule.
Hill JA; Southwood S; Sette A; Jevnikar AM; Bell DA; Cairns E
J Immunol; 2003 Jul; 171(2):538-41. PubMed ID: 12847215
[TBL] [Abstract][Full Text] [Related]
13. The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis.
Ting YT; Petersen J; Ramarathinam SH; Scally SW; Loh KL; Thomas R; Suri A; Baker DG; Purcell AW; Reid HH; Rossjohn J
J Biol Chem; 2018 Mar; 293(9):3236-3251. PubMed ID: 29317506
[TBL] [Abstract][Full Text] [Related]
14. Scanning the HIV genome for CD4+ T cell epitopes restricted to HLA-DP4, the most prevalent HLA class II molecule.
Cohen WM; Pouvelle-Moratille S; Wang XF; Farci S; Munier G; Charron D; Ménez A; Busson M; Maillère B
J Immunol; 2006 May; 176(9):5401-8. PubMed ID: 16622007
[TBL] [Abstract][Full Text] [Related]
15. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.
Mandic M; Castelli F; Janjic B; Almunia C; Andrade P; Gillet D; Brusic V; Kirkwood JM; Maillere B; Zarour HM
J Immunol; 2005 Feb; 174(3):1751-9. PubMed ID: 15661941
[TBL] [Abstract][Full Text] [Related]
16. Citrullination only infrequently impacts peptide binding to HLA class II MHC.
Sidney J; Becart S; Zhou M; Duffy K; Lindvall M; Moore EC; Moore EL; Rao T; Rao N; Nielsen M; Peters B; Sette A
PLoS One; 2017; 12(5):e0177140. PubMed ID: 28481943
[TBL] [Abstract][Full Text] [Related]
17. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
18. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.
Auger I; Sebbag M; Vincent C; Balandraud N; Guis S; Nogueira L; Svensson B; Cantagrel A; Serre G; Roudier J
Arthritis Rheum; 2005 Nov; 52(11):3424-32. PubMed ID: 16255019
[TBL] [Abstract][Full Text] [Related]
19. The CD4+ T cell repertoire specific for citrullinated peptides shows evidence of immune tolerance.
McElwee MK; Dileepan T; Mahmud SA; Jenkins MK
J Exp Med; 2023 Dec; 220(12):. PubMed ID: 37831103
[TBL] [Abstract][Full Text] [Related]
20. CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production.
Zeng G; Wang X; Robbins PF; Rosenberg SA; Wang RF
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3964-9. PubMed ID: 11259659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
